XML 33 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Consolidated Statements of Operations [Abstract]        
Product sales $ 1,085,408 $ 975,457 $ 2,135,323 $ 2,031,689
Cost of product sales 1,119,314 1,134,083 2,246,537 2,210,740
Gross loss (33,906) (158,626) (111,214) (179,051)
Operating expenses:        
Research and development expenses 170,030 149,176 317,020 290,648
Sales and marketing expenses 326,467 322,094 685,652 638,150
General and administrative expenses 513,964 469,559 1,165,000 1,114,412
Total operating expenses 1,010,461 940,829 2,167,672 2,043,210
Operating loss (1,044,367) (1,099,455) (2,278,886) (2,222,261)
Non-operating income (expense):        
Interest income 481 128 835 272
Change in fair value of warrant derivative liability 117,000 (55,000) 81,000 74,000
Financing and interest expense (86)    (827) (6)
Non-operating income / (expense), net 117,395 (54,872) 81,008 74,266
Net loss (926,972) (1,154,327) (2,197,878) (2,147,995)
Preferred stock deemed dividends (Note 9)       (726,378)   
Preferred stock dividends (2,658) (2,658) (5,316) (5,316)
Net loss applicable to common shareholders $ (929,630) $ (1,156,985) $ (2,929,572) $ (2,153,311)
Basic and diluted loss per share $ (0.02) $ (0.03) $ (0.08) $ (0.06)
Weighted average shares used in computing net loss per share:        
Basic and diluted 38,419,502 34,604,605 37,133,875 34,238,401